Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism

This publication has 40 references indexed in Scilit:

• Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort
  European Journal of Nuclear Medicine and Molecular Imaging, 2007
• Determination of tumour hypoxia with the PET tracer [18F]EF3: improvement of the tumour-to-background ratio in a mouse tumour model
  European Journal of Nuclear Medicine and Molecular Imaging, 2007
• The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON
  Radiotherapy and Oncology, 2006
• Prognostic Significance of [¹⁸F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
  Journal of Clinical Oncology, 2006
• EF5 binding and clinical outcome in human soft tissue sarcomas
  International Journal of Radiation Oncology*Biology*Physics, 2006
• Hypoxia in head and neck cancer: How much, how important?
  Head & Neck, 2005
• Hypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors
  Clinical Cancer Research, 2004
• Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1988